Breaking News Instant updates and real-time market news.

TSLA

Tesla

$356.33

0.29 (0.08%)

, GS

Goldman Sachs

$229.95

3.12 (1.38%)

12:56
08/14/18
08/14
12:56
08/14/18
12:56

Goldman not hired officially by Tesla at time of tweet, Bloomberg reports

Goldman Sachs had not been formally signed as a financial adviser by Tesla when CEO Elon Musk revealed plans last week to take the automaker private and said he'd secured the funding for the transaction, Bloomberg reports, citing people with knowledge of the matter. Conversations are ongoing between Goldman and Musk, the people said. Reuters reported earlier that Silver Lake Partners, like Goldman, hasn't been hired as an adviser in an official capacity.

TSLA

Tesla

$356.33

0.29 (0.08%)

GS

Goldman Sachs

$229.95

3.12 (1.38%)

  • 29

    Oct

TSLA Tesla
$356.33

0.29 (0.08%)

08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/10/18
MSCO
08/10/18
NO CHANGE
Target $291
MSCO
Equal Weight
Morgan Stanley says Tesla LBO doesn't seem feasible, equity buyout might be
Morgan Stanley analyst Adam Jonas said a leveraged buyout, or LBO, of Tesla does not appear to be feasible, even with less than $10B of incremental debt. However, he believes Tesla could consider an auction for its shares in the private equity market, financed by existing shareholders, new strategic investors, the possible divestiture of assets such as Tesla's autonomous and shared mobility assets and "possibly some help from SpaceX." However, Jonas notes that he has no knowledge of an equity buyout, or EBO, being considered by the company. He maintains an Equal Weight rating and $291 price target on Tesla shares.
GS Goldman Sachs
$229.95

3.12 (1.38%)

07/17/18
07/17/18
UPGRADE
Target $280

Outperform
Credit Suisse upgrades Goldman Sachs to Outperform on higher earnings power
As previously reported, Credit Suisse analyst Susan Roth Katzke upgraded Goldman Sachs to Outperform from Neutral after the company's Q2 EPS of $5.98 came in well above the firm's estimate and the consensus view. The quarterly report evidenced progress against the bank's previously stated growth initiatives, the health of its "record" banking pipeline and the realization of its operating leverage, said the analyst, who has a $280 price target on the stock.
07/18/18
OPCO
07/18/18
NO CHANGE
Target $335
OPCO
Outperform
Goldman Sachs price target raised to $335 from $304 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $335 from $304 following "excellent" results across businesses. The analyst reiterates an Outperform rating on the shares.
07/18/18
SOCG
07/18/18
UPGRADE
SOCG
Hold
Goldman Sachs upgraded to Hold from Sell at Societe Generale
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).

TODAY'S FREE FLY STORIES

ALGN

Align Technology

$298.21

7.43 (2.56%)

14:21
04/23/19
04/23
14:21
04/23/19
14:21
Hot Stocks
Align Technology short report posted to Tilson's Empire Financial Research site »

A short report regarding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 05

    Jun

PYPL

PayPal

$107.00

0.22 (0.21%)

14:20
04/23/19
04/23
14:20
04/23/19
14:20
Options
Call writing in Paypal ahead of earnings »

Call writing in Paypal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 09

    May

  • 14

    May

  • 22

    May

  • 03

    Jun

  • 11

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
04/23/19
04/23
14:17
04/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
04/23/19
04/23
14:16
04/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$39.54

-0.17 (-0.43%)

14:12
04/23/19
04/23
14:12
04/23/19
14:12
On The Fly
Trump Effect: Harley points to tariff impact as Trump vows to 'reciprocate' »

Shares of Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 09

    May

AG

First Majestic

$5.99

0.105 (1.78%)

14:05
04/23/19
04/23
14:05
04/23/19
14:05
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 10

    May

F

Ford

$9.45

0.105 (1.12%)

, AMZN

Amazon.com

$1,926.80

38.7 (2.05%)

14:02
04/23/19
04/23
14:02
04/23/19
14:02
Hot Stocks
Ford, Autonomic announce multi-year, global agreement with Amazon Web Services »

Ford Motor (F) and…

F

Ford

$9.45

0.105 (1.12%)

AMZN

Amazon.com

$1,926.80

38.7 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 10

    May

  • 22

    May

  • 03

    Jun

  • 24

    Jul

  • 23

    Oct

F

Ford

$9.46

0.115 (1.23%)

, AMZN

Amazon.com

$1,926.53

38.43 (2.04%)

14:01
04/23/19
04/23
14:01
04/23/19
14:01
Hot Stocks
Breaking Hot Stocks news story on Ford, Amazon.com »

Ford, Autonomic announce…

F

Ford

$9.46

0.115 (1.23%)

AMZN

Amazon.com

$1,926.53

38.43 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 10

    May

  • 22

    May

  • 03

    Jun

  • 24

    Jul

  • 23

    Oct

TWTR

Twitter

$39.82

5.43 (15.79%)

13:59
04/23/19
04/23
13:59
04/23/19
13:59
Recommendations
Twitter analyst commentary at Baird »

Twitter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

ADNT

Adient

$25.11

-0.43 (-1.68%)

13:55
04/23/19
04/23
13:55
04/23/19
13:55
Options
Adient put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

TNXP

Tonix Pharmaceuticals

$2.29

-0.035 (-1.51%)

13:54
04/23/19
04/23
13:54
04/23/19
13:54
Hot Stocks
Tonix Pharmaceuticals says USAMMDA exercising right to terminate CRADA »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

TNXP

Tonix Pharmaceuticals

$2.29

-0.035 (-1.51%)

13:52
04/23/19
04/23
13:52
04/23/19
13:52
Hot Stocks
Breaking Hot Stocks news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

AGN

Allergan

$142.87

2.6 (1.85%)

, TEVA

Teva

$15.14

0.435 (2.96%)

13:50
04/23/19
04/23
13:50
04/23/19
13:50
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$142.87

2.6 (1.85%)

TEVA

Teva

$15.14

0.435 (2.96%)

ALDR

Alder Biopharmaceuticals

$13.55

0.78 (6.11%)

AMGN

Amgen

$180.01

3.81 (2.16%)

BHVN

Biohaven Pharmaceutical

$63.34

2.39 (3.92%)

LLY

Eli Lilly

$117.60

2.16 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

TWTR

Twitter

$39.95

5.56 (16.17%)

13:44
04/23/19
04/23
13:44
04/23/19
13:44
Recommendations
RBC 'more constructive' on Twitter post results, boosts price target to $38 »

In a post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

BRFS

BRF S.A.

$7.54

0.44 (6.20%)

13:40
04/23/19
04/23
13:40
04/23/19
13:40
Options
Renewed call buying in BRF SA as shares rally 6.5% »

Renewed call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PW

Power REIT

$5.74

-0.075 (-1.29%)

13:39
04/23/19
04/23
13:39
04/23/19
13:39
Hot Stocks
Cascadilla Capital Partners urges sale or liquidation of Power REIT »

Todd Merkle, Managing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$31.44

1.21 (4.00%)

13:36
04/23/19
04/23
13:36
04/23/19
13:36
Recommendations
PulteGroup analyst commentary  »

PulteGroup price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 08

    May

MBRX

Moleculin Biotech

$1.60

-1.37 (-46.13%)

13:35
04/23/19
04/23
13:35
04/23/19
13:35
Hot Stocks
Sabby Management reports 7.14% passive stake in Moleculin Biotech »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

LMT

Lockheed Martin

$336.62

21.38 (6.78%)

13:31
04/23/19
04/23
13:31
04/23/19
13:31
Hot Stocks
Lockheed Martin receives $362M contract for MLRS launchers »

The U.S. Army awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 29

    May

  • 05

    Jun

13:30
04/23/19
04/23
13:30
04/23/19
13:30
General news
Treasury Action: yields remain lower after a well received 2-year auction »

Treasury Action: yields…

TCEHY

Tencent

$0.00

(0.00%)

, KKR

KKR

$23.76

0.33 (1.41%)

13:28
04/23/19
04/23
13:28
04/23/19
13:28
Periodicals
Epic workers describe 'Fortnite' working environment as toxic, Polygon says »

Current and former…

TCEHY

Tencent

$0.00

(0.00%)

KKR

KKR

$23.76

0.33 (1.41%)

DIS

Disney

$133.00

1.3 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 08

    May

  • 15

    May

  • 11

    Jun

TSLA

Tesla

$264.55

1.65 (0.63%)

13:26
04/23/19
04/23
13:26
04/23/19
13:26
Hot Stocks
Tesla electric vehicle challenger Lucid Motors appoints Peter Rawlinson as CEO »

Electric car start-up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

PAGS

PagSeguro Digital

$26.03

0.375 (1.46%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Options
PagSeguro Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$276.37

4.14 (1.52%)

, CRM

Salesforce

$160.44

1.69 (1.06%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
Stephens eCommerce analysts to hold an analyst/industry conference call »

Analysts provide an…

ADBE

Adobe

$276.37

4.14 (1.52%)

CRM

Salesforce

$160.44

1.69 (1.06%)

SHOP

Shopify

$223.04

-1.28 (-0.57%)

SAP

SAP

$114.13

0.36 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 03

    Jun

  • 23

    Jun

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.